Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208256 · ClinicalTrials.gov registry record
Food Intake and the Adolescent Brain
A clinical trial of Adolescent and Feeding Behavior, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 63
- Enrollment target
- 1
- Study location
NCT04208256: Completed study of Adolescent and Feeding Behavior, sponsored by University of Colorado, Denver.
NCT04208256 is a study of Adolescent and Feeding Behavior that has completed, run by University of Colorado, Denver. The registered enrollment target is 63 participants, below the 259-participant average among 15 other Adolescent trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04208256, a study of Adolescent and Feeding Behavior, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
The brain plays an integral role in how and what people eat. However, the brain's contribution to overeating is not well understood during sensitive developmental periods such as adolescence, when excessive weight gain and obesity prevalence are a significant concern.The proposed study will use functional magnetic resonance imaging to examine how the brain's response to excess energy is related to overeating in adolescents with and without obesity.
Primary Outcome
Brain function will be quantified via the blood oxygen level-dependent (BOLD) signal in the hypothalamus, insula, anterior cingulate cortex, nucleus accumbens, amygdala, and superior and inferior frontal gyri, and connectivity between these brain regions.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Energy Stimulus
Study Locations (1)
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2019-12-30 |
| Est. Completion | 2024-09-30 |
What the finished NCT04208256 record still lists
NCT04208256 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 259-participant average among 15 other Adolescent trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Adolescent appearing as the primary indexed condition, and to 1 intervention - of which Energy Stimulus is the first listed.
NCT04208256 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04208256 about?
NCT04208256 is a clinical study titled "Food Intake and the Adolescent Brain". The brain plays an integral role in how and what people eat. However, the brain's contribution to overeating is not well understood during sensitive developmental periods such as adolescence, when excessive weight gain and obesity prevalence are a significant concern.The proposed study will use func...
What is the current status of trial NCT04208256?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2019-12-30. Estimated completion is 2024-09-30.
What conditions does trial NCT04208256 study?
This clinical trial studies the following conditions: Adolescent, Feeding Behavior, Brain.
What interventions are being tested in trial NCT04208256?
The interventions under investigation include: Energy Stimulus (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04208256?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04208256 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adolescent
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04208256's enrollment target sits among peer trials
63 11th of 15 higher than 5 of 15 other Adolescent trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adolescent trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Evidence-based Family Support Program for Parents and Children in Palestine: a Theory-based Intervention
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Neural Connectivity During Therapy for Adolescent PTSD
RECRUITING · NA
-
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RECRUITING · Phase 2
-
Enhancing Brain And Mental Health Through Breathing Practice
RECRUITING · NA
-
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI